Quality over Quantity: a Necessary Path for Clinical Research Transformation in China

Da Xu,Bao-Cai Xing

DOI: https://doi.org/10.21037/hbsn-2020-5

2020-01-01

HepatoBiliary Surgery and Nutrition

Abstract:HepatoBiliary Surg Nutr 2020;9(5):684-686 | http://dx.doi.org/10.21037/hbsn-2020-5 Since the Chinese economic reform in 1978, its medical field has made remarkable progress in the past 40 years. In most medical fields, China’s diagnosis and treatment methods are comparable to the international high standards. In recent years, with the continuous expansion of the medical research team and the improvement of laboratory research equipment and methods, China has achieved some influential and internationally recognized research outcomes. However, overall, China still lags behind developed countries in terms of high-level original medical research, especially in high evidence-based medical research (1). China has a large population base, and the number of cases is among the highest in the world. If Chinese doctors can make full use of these patient resources, it would be very beneficial to conduct research on disease pathogenesis and diagnosis and treatment. However, many clinical studies currently focus on quantity rather than quality, so it is difficult to obtain research results that can change clinical practice. There are subjective and objective factors leading to this situation. What is the future of clinical research in China? This question will be discussed from the following four aspects.